Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hygia Pharmaceuticals LLC is currently overseeing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 pending office action is being reviewed by 1 distinct examiner, which suggests a very focused prosecution stage for the company's current intellectual property. The data indicates that this activity is occurring within 1 distinct art unit, pointing to a specific technical niche within the broader biotechnology field.
The busiest examiner identified for this portfolio is RAMACHANDRAN, UMAMAHESWARI, who is currently handling 1 busiest examiner pending office action. Since this 1 busiest examiner pending office action represents the total number of pending actions for the company, the entire prosecution effort is currently concentrated under this identified individual. This concentration means that the company's immediate success in the Biotechnology & Pharmaceuticals sector depends on the specific feedback from this examiner.
Practitioners should focus on the examination patterns of RAMACHANDRAN, UMAMAHESWARI, as there are no other examiners currently involved in the portfolio. The use of 1 distinct art unit further simplifies the procedural requirements, as the company does not have to manage the varying standards of multiple patent office divisions. A strategy tailored to the 1 distinct examiner and art unit is essential for resolving the current pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMACHANDRAN, UMAMAHESWARI | 1 | 54.6% | +53.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18351368 | DRINK PRODUCT AND USE THEREOF | RAMACHANDRAN, UMAMAHESWARI | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18351368 | DRINK PRODUCT AND USE THEREOF | RAMACHANDRAN, UMAMAHESWARI | 1627 | §102§103§112DP | Non-Final OA | — | Pending | Jul 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial